NDXH:PA:PA-Amundi Nasdaq-100 EUR Hedged Daily UCITS (EUR)

ETF | Others |

Last Closing

USD 484.1

Change

+4.35 (+0.91)%

Market Cap

USD 0.58B

Volume

988.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.61 (+1.30%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+0.80 (+0.14%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.07 (+0.02%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.10 (+0.26%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.87 (+1.10%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.10 (+0.02%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.10 (+0.31%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

+0.07 (+0.12%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.16 (-2.18%)

USD 5.25B

ETFs Containing NDXH:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.14% 13% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.14% 13% F 25% F
Trailing 12 Months  
Capital Gain 12.40% 52% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.40% 51% F 64% D
Trailing 5 Years  
Capital Gain 120.30% 95% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 120.30% 95% A 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 17.16% 84% B 81% B-
Dividend Return 17.16% 83% B 80% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 25.29% 14% F 44% F
Risk Adjusted Return 67.85% 45% F 71% C-
Market Capitalization 0.58B 67% D+ 70% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.